Delivery Order SPE2DB20D1004-SPE2DB25FNKTR
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $13,132.00 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order valued at $6,059.18 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, PA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,913.51 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) with an ultimate completion date of August 12, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,112.43 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Xeljanz 5 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of September 5, 2025, and represents a non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,519.47 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xeljanz is a prescription immunosuppressant medication used to treat rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at $25,569.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets in quantities of 60 units. This firm fixed price delivery order, issued on July 30, 2025, is set to be completed by July 31, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its...
- The Defense Logistics Agency awarded a delivery order valued at $9,729.05 to AmerisourceBergen Drug Corp for 60 tablets of Xeljanz 5 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $18,191.81 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $14,182.44 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,568.39 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-competitive delivery against the vendor's existing Indefinite Delivery Contract (IDC). The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....